BioSpace News Archive

iECURE, today announced that data showing the potential for the company’s gene editing approach to treating ornithine transcarbamylase (OTC) deficiency, a urea cycle disorder, will be presented in the Presidential Symposium and Presentation of Top Abstracts Plenary Session at the American Society of Gene & Cell Therapy (ASGCT) annual meeting.

Cyclo Therapeutics, Inc. announced that N. Scott Fine, Chief Executive Officer of Cyclo Therapeutics, will present at the H.C. Wainwright Global Investment Conference being held May 23-26, 2022 in Miami, FL and virtually.

Evolus, Inc., a performance beauty company with a customer-centric approach focused on delivering breakthrough products, celebrates the three-year anniversary of the launch of its flagship neurotoxin product, Jeuveau®, the first and only neurotoxin dedicated exclusively to aesthetics.

Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19 TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period.

Kane Biotech Inc., announced that it has obtained ISO 13485:2016 certification for its quality management system specific to its ongoing efforts to design and develop novel medical devices for the wound care market.

Fortress Biotech, Inc. announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in two investor conferences in May 2022.

Senti Bio, a leading gene circuit company, today announced three presentations at the American Society of Gene and Cell Therapy (ASGCT) annual meeting being held in Washington D.C., May 16–19, 2022.

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2022 and provide a corporate strategic update on Thursday, May 19, 2022, after the close of trading.

The Foundation for Sarcoidosis Research, the leading international nonprofit organization dedicated to finding a cure and improving care for sarcoidosis patients, is pleased to announce the American Thoracic Society /Foundation for Sarcoidosis Research Grant awardee, Auyon Ghosh MD, MPH, for his proposal “Gene expression signatures of extrapulmonary sarcoidosis.”

Athos Therapeutics, Inc., a late-stage preclinical biotech company using artificial intelligence to develop small molecule therapeutics for immune-mediated diseases and cancer, announced that Abraham Verghese, MD, MACP has been named to the Company’s Board of Directors.